ClinConnect ClinConnect Logo
Search / Trial NCT06295640

Relative Contribution of Brain Insulin Action for Postprandial Metabolism

Launched by UNIVERSITY OF ULM · Mar 5, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Postprandial Glucose Metabolism Brain Insulin Action Insulin Sensitivity Insulin Secretion Endogenous Glucose Production Menstrual Cycle Sex Differences Proglucagon Cleavage Products

ClinConnect Summary

This clinical trial is studying how insulin, a hormone that helps control blood sugar levels, works in the brain and how it affects our body's metabolism after eating. Researchers want to understand if there are differences between men and women in how the brain regulates metabolism, especially considering the impact of the menstrual cycle in women. Participants will take part in tests that measure how their bodies handle sugar, using a method that involves taking a nasal spray with insulin on some days and a placebo (an inactive spray) on other days.

To join this study, participants should be between the ages of 65 and 75, have a Body Mass Index (BMI) of less than 24, and should not have any major health issues or be using hormonal birth control. Those with a history of drug or alcohol abuse, smoking, or certain health conditions that could affect safety or the study's success will not be eligible. If you choose to participate, you'll have the chance to contribute to important research that could improve our understanding of glucose metabolism and how it varies between individuals.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • BMI \< 24 kg/m2
  • no known primary diseases
  • no hormonal contraception
  • Exclusion Criteria:
  • Alcohol or drug abuse
  • Smoking
  • At screening: Hb \< 12 g/dl for women and Hb \< 14 g/dl for men
  • Any (clinical) condition that would endanger participant's safety or question scientific success according to a physician's opinion.

About University Of Ulm

The University of Ulm is a leading academic institution located in Germany, renowned for its commitment to cutting-edge research and innovation in the fields of medicine and health sciences. As a clinical trial sponsor, the university leverages its robust network of researchers and clinical experts to advance medical knowledge and improve patient outcomes. With a focus on interdisciplinary collaboration, the University of Ulm conducts comprehensive clinical studies that adhere to the highest ethical standards and regulatory guidelines. Through its research initiatives, the university aims to contribute significantly to the development of new therapies and treatment modalities, fostering a deeper understanding of various health conditions.

Locations

Ulm, , Germany

Patients applied

0 patients applied

Trial Officials

Martin Heni, MD

Principal Investigator

University of Ulm

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported